HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alireza R Rezaie Selected Research

Dysprothrombinemia

1/2022Antithrombin Resistance Rescues Clotting Defect of Homozygous Prothrombin-Y510N Dysprothrombinemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alireza R Rezaie Research Topics

Disease

11Inflammation (Inflammations)
01/2022 - 06/2009
9Autolysis
05/2008 - 05/2002
8Hemorrhage
07/2022 - 03/2007
6Thrombosis (Thrombus)
07/2022 - 01/2017
5Venous Thrombosis (Deep-Vein Thrombosis)
01/2021 - 01/2017
5Sepsis (Septicemia)
11/2015 - 08/2007
2Venous Thromboembolism
07/2022 - 07/2017
2Infections
01/2020 - 11/2015
2Neoplasms (Cancer)
04/2019 - 03/2007
2Polyps
01/2018 - 02/2014
2Melanoma (Melanoma, Malignant)
01/2018 - 02/2014
2Endotoxemia
10/2017 - 11/2015
2Reperfusion Injury
01/2016 - 02/2015
2Necrosis
03/2009 - 03/2007
1Thromboinflammation
07/2022
1Hemophilia A (Haemophilia)
07/2022
1Thrombocytopenia (Thrombopenia)
07/2022
1Dysprothrombinemia
01/2022
1COVID-19
01/2021
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2020
1Malaria
01/2020
1Cardiovascular Infections
04/2019
1Heart Failure
04/2019
1Myocardial Ischemia (Ischemic Heart Diseases)
04/2019
1Heart Diseases (Heart Disease)
04/2019
1Neoplasm Metastasis (Metastasis)
01/2018
1Hypertrophy
01/2018
1Fibrosis (Cirrhosis)
01/2018
1Peritonitis
10/2017
1Thrombophilia
07/2017
1Pulmonary Embolism
01/2017
1Activated Protein C Resistance (APC Resistance)
11/2015
1Hemophilia B (Haemophilia B)
06/2015
1Vascular Diseases (Vascular Disease)
11/2013
1Acute Kidney Injury (Acute Renal Failure)
10/2010
1Pathologic Processes
04/2009

Drug/Important Bio-Agent (IBA)

19Protein CIBA
11/2021 - 09/2004
13AnticoagulantsIBA
01/2022 - 09/2004
10AntithrombinsIBA
01/2022 - 05/2002
8Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2004
8ThrombinFDA Link
09/2014 - 09/2004
8Peptide Hydrolases (Proteases)FDA Link
02/2014 - 05/2002
7Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 07/2003
6SerpinsIBA
07/2017 - 07/2003
5Protein SIBA
07/2017 - 07/2005
4HMGB1 Protein (HMG1)IBA
01/2018 - 10/2011
3AntigensIBA
01/2022 - 01/2017
3PolyphosphatesIBA
01/2020 - 02/2014
3Peptides (Polypeptides)IBA
01/2018 - 03/2009
3Factor X (Stuart Factor)IBA
11/2014 - 07/2005
3ChymotrypsinogenIBA
11/2014 - 07/2003
3Endothelial Protein C ReceptorIBA
10/2011 - 03/2007
3Factor Xa (Coagulation Factor Xa)IBA
09/2005 - 05/2002
2Prothrombin (Factor II)IBA
01/2022 - 07/2017
2Histidine (L-Histidine)FDA Link
01/2022 - 01/2020
2Histones (Histone)IBA
10/2021 - 02/2014
2Epidermal Growth Factor (EGF)IBA
01/2020 - 09/2005
2AMP-Activated Protein KinasesIBA
04/2019 - 02/2015
2IntegrinsIBA
10/2017 - 04/2009
2Biological ProductsIBA
11/2015 - 04/2009
2CytokinesIBA
02/2015 - 03/2009
2Pharmaceutical PreparationsIBA
10/2011 - 03/2007
2ChymotrypsinFDA Link
05/2008 - 09/2004
2Serine Proteases (Serine Protease)IBA
08/2006 - 09/2004
1VaccinesIBA
07/2022
1Poly I-CIBA
11/2021
1GlycosaminoglycansIBA
10/2021
1Viral ProteinsIBA
01/2021
1Blood Proteins (Serum Proteins)IBA
01/2020
1Mitogen-Activated Protein KinasesIBA
04/2019
1Blood Coagulation Factors (Coagulation Factor)IBA
04/2019
1Mechanistic Target of Rapamycin Complex 1IBA
04/2019
1von Willebrand FactorIBA
01/2018
1Integrin alpha3beta1IBA
10/2017
1factor V LeidenIBA
07/2017
1prothrombin complex concentrates (PPSB)IBA
01/2017
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2017
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
06/2015
1Codon (Codons)IBA
11/2014
1Adenosine (Adenocard)FDA LinkGeneric
09/2014
1Small Interfering RNA (siRNA)IBA
02/2014
1Nuclear Proteins (Protein, Nuclear)IBA
02/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
02/2014
1Receptor for Advanced Glycation End ProductsIBA
02/2014
1Purinergic P2Y1 ReceptorsIBA
02/2014
1Pattern Recognition ReceptorsIBA
02/2014
1Messenger RNA (mRNA)IBA
02/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2014
1ThrombomodulinIBA
02/2014
1Transforming Growth Factor beta (TGF-beta)IBA
10/2010
1Phospholipases (Phospholipase)IBA
01/2010
1Proteinase-Activated ReceptorsIBA
06/2009
1drotrecogin alfa activated (Xigris)FDA Link
04/2009
1NF-kappa B (NF-kB)IBA
03/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009
1Thrombin Receptors (Thrombin Receptor)IBA
03/2009
1Monomeric GTP-Binding ProteinsIBA
03/2009
1TrypsinIBA
05/2008
1StaurosporineIBA
03/2007

Therapy/Procedure

3Therapeutics
01/2020 - 11/2015